Please login to the form below

Not currently logged in


This page shows the latest safety news and features for those working in and with pharma, biotech and healthcare.

BMS’ new JAK inhibitor enters regulatory pathways

BMS’ new JAK inhibitor enters regulatory pathways

In spite of ongoing safety concerns for the class as a whole, BMS’s selective JAK inhibitor deucravacitinib has been accepted for review by regulatory agencies. ... The ability of Janus kinase (JAK) inhibitors to modify the immune system by inhibiting

Latest news

More from news
Approximately 86 fully matching, plus 2,374 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 216 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 50 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 125 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...
Six ways to improve diversity in clinical trials
Diversity is becoming increasingly important as a focus of clinical trials. This whitepaper gives six approaches that could be implemented to help make diversity a bigger focus on your clinical...